| Similar Articles |
|---|
 |
Salon.com
July 28, 2000
Kate Scanell |
Contributing to genocide By giving HIV deniers a global platform, South African President Mbeki has put countless lives at risk.   |
Managed Care
March 2005
Martin Sipkoff |
Direct-to-Consumer Ads Garner Mixed Outcomes DTC advertising's reputation as a bully may be largely overstated. There's little evidence that sales of specific drugs increase, and there may be some benefit. |
Salon.com
August 21, 2001
David Horowitz |
The AIDS obstructionists As the AIDS epidemic spins out of control, special interest groups are preventing one of the only things that can work -- mandatory testing... |
BusinessWeek
April 1, 2010
Bennett & Randall |
Will an AIDS Pill a Day Keep the Virus Away? Drugmaker Gilead is betting the one-pill PrEP treatment will slow the virus' spread - as are some of the world's top health agencies and philanthropists. |
Fast Company
March 2015
J.J. McCorvey |
How Drug Company Gilead Outpaces Its Competitors -- And Common Diseases Over the past few years, Gilead has ushered through four effective new treatments for HIV alone. |
American Journal of Nursing
March 2010
David E. Vance |
Aging with HIV: Clinical Considerations for an Emerging Population Since the advent of highly active antiretroviral therapy, HIV infection has become a chronic, albeit life-threatening, condition that can be managed; therefore, more and more people are growing older with HIV. |
BusinessWeek
August 13, 2007
Arlene Weintraub |
Putting Drug Ads Back In The Bottle Efforts to curb direct-to-consumer drug advertising are growing, but so far have met little success. |
Pharmaceutical Executive
September 1, 2010 |
To Brand or Not to Brand? The effectiveness of direct-to-consumer prescription advertising hinges on a consumer's thirst for information. A new study intimates the less info consumers are given up front, the more they seem willing to learn. |
Managed Care
February 2007
MargaretAnn Cross |
How Much Trouble Does Health Care Marketing Cause? Whether for drugs, imaging, surgery, or emergency services, direct-to-consumer advertising sparks lively debate. |
Salon.com
December 1, 2000
Fiona Morgan |
It's World AIDS Day ... again Americans with insurance now improve with new drugs, but the disease is on a rampage across the rest of the world... |
Salon.com
June 22, 2001
Alicia Montgomery |
A deadly taboo Is homophobia in the black community fanning the flames of HIV infection among African-Americans, the hardest-hit population outside sub-Saharan Africa? |
Nursing
January 2011
Carl A. Kirton |
HIV: The Changing Epidemic Since its emergence in the early 1980s, HIV infection in the United States has evolved from an acute debilitating condition to a chronic, treatable illness. |
BusinessWeek
November 4, 2009
Arlene Weintraub |
Ask Your Doctor If This Ad Is Right for You The drug industry is spending billions on TV ads, but they may be scaring consumers away |
BusinessWeek
September 2, 2010
Simeon Bennett |
David Margolis' Fight to End AIDS The North Carolina professor is relying on Zolinza, a rarely used Merck cancer drug, to stamp out AIDS. |
American Journal of Nursing
March 2010
Bradley-Springer et al. |
Every Nurse Is an HIV Nurse The evolution of HIV infection into a chronic disease has implications across all clinical care settings. Every nurse should be knowledgeable about the disease in order to provide high-quality care to people with or at risk for HIV. |
BusinessWeek
March 7, 2005
Amy Barrett |
Will Drugmakers Back Off The Hard Sell? Drug ads need to return to more balanced communication of risks and benefits and not depend so much on catchy phrases and images. The question is whether the industry is ready to take that lesson to heart. |
BusinessWeek
November 19, 2009
Catherine Arnst |
Why Drugmakers Don't Twitter The FDA has so far failed to craft rules clarifying how pharmaceutical companies can participate in online discussions. |
BusinessWeek
February 9, 2004
John Carey |
Drug Ads Need Stronger Medicine New FDA guidelines may not go far enough in making sure pharmaceutical ads are used appropriately. |
Salon.com
May 18, 2000
Sabin Russell |
The dream and the coming disaster AIDS threatens to ravage the hopes of South Africa's young democracy. Don't expect leaders to get excited because a few companies cut the cost of HIV drugs. |
Salon.com
September 14, 2000
David Tuller |
Seeing red Gay men have long been infuriated by a government ban on their donating blood. This week the FDA is reconsidering its position. |
Salon.com
May 21, 2002
Peter Kurth |
Quack record Bestselling health and fitness guru Gary Null weighs in on AIDS. Almost all of what he says is useless, dangerous and just plain wrong... |
BusinessWeek
August 5, 2010
Bennett & Randall |
AIDS Drugs Flow to the Third World Drugmakers, once blasted for their practices, are slashing prices and licensing AIDS drugs for free to nonprofits or local manufacturers in developing countries. |
The Motley Fool
August 22, 2007
Brian Orelli |
Regulating the Drug Pushers The FDA might get a little tougher on drug ads, following a report that they may not be watching advertisers claims closely enough, or warning patients about side effects strongly enough. |
Salon.com
March 28, 2001
Nina Siegal |
A plague undetected Did shady backroom hormone treatments and dirty needles cause a killer outbreak of HIV in the transgender community? |
Salon.com
June 25, 2001
Daryl Lindsey |
AIDS activists change their act On the eve of a United Nations conference, the once-militant ACT-UP revises its tactics and focus... |
American Family Physician
May 15, 2002 |
HIV in Women What are HIV and AIDS?... How do women become infected with HIV?... Is HIV infection different in women and men?... What precautions can be taken to avoid getting HIV during sex?... What should I do if I think I may be infected?... |
American Family Physician
July 15, 2004
Joel E. Gallant |
HIV Counseling, Testing, and Referral By the year 2005, the CDC seeks to achieve the following: reduce annual new HIV infections from the current estimated 40,000 cases to 20,000 cases through the use of interventions such as counseling, HIV testing, and referral |
BusinessWeek
February 10, 2011
Rob Waters |
Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology. |
BusinessWeek
August 15, 2005
Barrett & Weintraub |
Drugmakers Are Changing Channels All those "Ask your doctor if it's right for you" ads on TV haven't delivered. As drugmakers labor to develop more educational and balanced pitches, they're also trying to better target their messages. |
Pharmaceutical Executive
April 1, 2011 |
Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help. |
Pharmaceutical Executive
July 30, 2007
Walter Armstrong |
Tibotec Gets AIDS With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, Tibotec is in it to win it. And end it. |
Pharmaceutical Executive
June 1, 2007
Stan Bernard |
Consumerization: Pandora's Pillbox By going direct-to-consumer, the industry unwittingly unleashed a swarm of opportunities for other players to enter the pharmaceutical fray. And they made the most of it. Now, a decade later, pharma is feeling the fallout in consumer trust and product value. It's time to take back control. |
Chemistry World
August 4, 2008
Pete Mitchell |
Vaccine failures shake up HIV research Prospects for an HIV vaccine have receded with the July decision by the US government National Institutes of Health (NIH) to cancel trials of its main vaccine candidate. |
Chemistry World
April 14, 2008
Ananyo Bhattacharya |
Psychiatric Drug Ads 'Frequently Misleading' Advertisements for psychiatric drugs - including many top-selling antidepressants - often make claims that are either misleading or impossible to verify, according to a new US study. |
The Motley Fool
December 14, 2006
Stephen Albainy-Jenei |
Merck Gets Punk'd by Thailand Thailand issues a compulsory license to manufacture a generic version of Merck's patented AIDS drug. This is an act of humanitarian aid, but it is also an avenue for price and profit erosion worldwide. |
The Motley Fool
April 26, 2011
Luke Timmerman |
FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs Good news for Vertex? |
The Motley Fool
January 21, 2010
Brian Orelli |
Here's That Critical Merck Info You Missed Announcing clinical trial failures in a FAQ? Really? |
The Motley Fool
April 6, 2009
Brian Orelli |
FDA to Search Engines: You Lose! FDA cracks down on pharma ads, but search engines are the real losers. The FDA wants the drugmakers to stop making claims in sponsored link advertisements. |
Pharmaceutical Executive
June 1, 2006
Philip A. George |
Alternative Media: Online Med Sites Gain Patient Trust Pharma could benefit from a little less TV. |
Reason
April 2001
Ronald Bailey |
Goddamn the Pusher Man Why does everybody seem to hate the pharmaceutical industry? |
Salon.com
October 20, 2000
David Tuller |
The buzz about blow jobs A study now underway hopes to isolate risk factors of transmitting HIV through oral sex... |
Searcher
June 2012
Stephanie C. Ardito |
The Medical Digital: How Safe Are the Prescription Drugs we Take? Monitoring Adverse Events and Recalls For general information about prescription and clinical trial drugs, the following websites have been around for a while and have excellent reputations. |
Pharmaceutical Executive
April 1, 2011 |
Winning Beyond the Molecule It can take both a clinical and non-clinical approach to win the differentiation competition. |
BusinessWeek
August 26, 2010
Tom Randall |
Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer. |
BusinessWeek
April 1, 2010 |
The Case for PrEP The acronym stands for pre-exposure prophylaxis, meaning the use of therapeutic drugs to prevent infection. In the absence of an HIV vaccine, here are three reasons PrEP may be the next best thing. |
Salon.com
June 30, 2000
Sabin Russell |
Circumcision may cut AIDS risk Researchers have routinely dismissed the idea that the procedure can stem the spread of HIV. That may be about to change. |
The Motley Fool
September 2, 2008
Brian Orelli |
Lipitor Is Back on the Tube Direct-to-consumer ads have to walk a line. |
Mother Jones
August 2000
Jacob Levenson |
A Time for Healing African Americans now account for the majority of new AIDS cases. But a crusading Harlem pastor believes the black church can slow the epidemic's spread. |
The Motley Fool
December 11, 2008
Brian Orelli |
Drugmakers Could Lose Their Greatest Weapon Congress is thinking about putting limits on direct-to-consumer advertisements. The pharmaceutical industry trade group makes a preemptive strike. |
Salon.com
May 1, 2001
Daryl Lindsey |
Amy and Goliath A first-year law student brought a giant pharmaceutical to its knees. But will her victory for South Africa's AIDS sufferers deprive the world of new medicines? |
